C. Cecchin

Kidney Function and 24-Hour Proteinuria in Patients with Fabry Disease during 36 Months of Agalsidase Alfa Enzyme Replacement Therapy: A Brazilian Experience

C. Netto, R. Giugliani, U. Matte, 2009, Renal failure.

White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up.

C. Netto, R. Giugliani, U. Matte, 2006, Arquivos de neuro-psiquiatria.

CNS involvement in Fabry disease: Clinical and imaging studies before and after 12 months of enzyme replacement therapy

R. Giugliani, U. Matte, L. Vedolin, 2004, Journal of Inherited Metabolic Disease.

Depressive Symptoms in Machado-Joseph Disease (SCA3) Patients and Their Relatives

T. Carvalho, M. Saraiva-Pereira, J. Sequeiros, 2006, Public Health Genomics.

Social differences in tooth decay occurrence in a sample of children aged 3 to 5 in north-east Italy.

E. Stellini, A. Olivieri, R. Ferro, 2010, Community dental health.

A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3)

C. Kieling, L. Jardim, J. Saute, 2008, European journal of neurology.

Genomic analysis of Brazilian patients with Fabry disease.

C. Netto, R. Giugliani, U. Matte, 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.